October 17, 2024
It has been 24 years since a pharmaceutical was last approved for posttraumatic stress disorder (PTSD). The condition is notoriously difficult to treat, with up to […]
October 15, 2024
TOPLINE: Bright light therapy (BLT) is associated with a 41% remission rate in patients with nonseasonal depressive disorders, significantly higher than the remission rates reported with […]
October 15, 2024
As at-home, do-it-yourself (DIY) brain stimulation devices like transcranial direct current stimulation (tDCS) gain popularity for common psychiatric conditions like depression, anxiety, and posttraumatic stress disorder […]
October 15, 2024
TOPLINE: Deprescribing antihypertensive medications is associated with a 12% lower likelihood of cognitive decline in older nursing home residents, a new study suggests. The association was […]
October 14, 2024
“Death cafes” — where people gather to discuss death and dying over tea and cookies — have gained momentum in recent years offering a unique way […]
October 11, 2024
A psychosocial intervention designed to improve depressive symptoms and promote good parenting skills can be an effective way of treating male postpartum depression, according to new […]
October 10, 2024
Since the COVID-19 pandemic began in 2020, Canadian healthcare professionals have seen a significant increase in several types of addictions, including alcohol, opioids, stimulants, and gambling. […]
October 8, 2024
Mild or disabling hearing loss in middle-aged and older adults is associated with cognitive impairment, new findings show. However, unlike in previous studies, investigators found no […]
October 7, 2024
Black box warnings added to antidepressant medications on increased risk for suicidality were associated with a decline in mental health treatment and an increase in suicide […]